Prescription and efficacy of daclatasvir and sofosbuvir +/- ribavirin for hepatitis C infection, including patient-reported outcomes, in routine practice in three European countries: the CMPASS-EU cohort study.
Bourgeois, Stefan; Van Erpecum, Karel; DELWAIDE, Jeanet al.
DELWAIDE, Jean ; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service de gastroentérologie, hépatologie, onco. digestive
Prescription and efficacy of daclatasvir and sofosbuvir +/- ribavirin for hepatitis C infection, including patient-reported outcomes, in routine practice in three European countries: the CMPASS-EU cohort study.